NORRIS

Norris Medicines Share Price

₹17.00 +0.37 (2.22%)

27 Apr, 2025 18:42

SIP TrendupStart SIP in NORRIS

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month -2.3%
  • Over 3 Month -31.03%
  • Over 6 Month -0.58%
  • Over 1 Year + 34.18%
SIP Lightning

Smart Investing Starts Here Start SIP with Norris Medicines for Steady Growth!

Invest Now

Norris Medicines Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Norris Medicines Financials

Norris Medicines Technicals

EMA & SMA

Current Price
₹17.00
+ 0.37 (2.22%)
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹17.25
  • 50 Day
  • ₹18.19
  • 100 Day
  • ₹18.70
  • 200 Day
  • ₹18.14

Resistance and Support

17.05 Pivot Speed
  • R3 19.35
  • R2 18.60
  • R1 17.80
  • S1 16.25
  • S2 15.50
  • S3 14.70

What's your outlook on Norris Medicines?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Norris Medicines has an operating revenue of Rs. 4.59 Cr. on a trailing 12-month basis. An annual revenue de-growth of -32% needs improvement, Pre-tax margin of -19% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at D+ which indicates heavy supply, Group Rank of 85 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Norris Medicines Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-02-13 Quarterly Results & Others Inter-alia, to consider 1. Requests from Mr. Nimish Bhishma Thakore, for reclassification from Promoter / Promoter Group into Public Category. 2. Other business matters.
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results
2024-02-14 Quarterly Results

Norris Medicines F&O

Norris Medicines Shareholding Pattern

34%
0.01%
0.06%
20.72%
45.21%

About Norris Medicines

  • NSE Symbol
  • NORRIS
  • BSE Symbol
  • 524414
  • Managing Director
  • Mr. Vimal Shah
  • ISIN
  • INE744C01029

Similar Stocks to Norris Medicines

Norris Medicines FAQs

Norris Medicines share price is ₹17 As on 27 April, 2025 | 18:28

The Market Cap of Norris Medicines is ₹17 Cr As on 27 April, 2025 | 18:28

The P/E ratio of Norris Medicines is -20.4 As on 27 April, 2025 | 18:28

The PB ratio of Norris Medicines is -1.3 As on 27 April, 2025 | 18:28

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23